or pharmaceutically acceptable salt forms thereof, wherein A, B, C, D, R1, and R2 are defined in the present specification, which are useful as metalloprotease, TNF-α, and/or aggrecanase inhibitors."/>
公开/公告号US6884806B2
专利类型
公开/公告日2005-04-26
原文格式PDF
申请/专利号US20020271441
申请日2002-10-16
分类号C07D471/04;C07D455/02;A61K31/47;A61K31/4745;A61P19/02;
国家 US
入库时间 2022-08-21 22:20:05